Shukra Pharmaceuticals Limited (BOM:524632)
35.35
+1.68 (4.99%)
At close: Apr 16, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 15.48 billion as of April 16, 2026. Its market cap has increased by 49.79% in one year.
Market Cap
15.48B
Enterprise Value
15.38B
Revenue
645.69M
Ranking
n/a
PE Ratio
89.14
Stock Price
35.35
Market Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 15.48B, an increase of 33,432.59%. That is a compound annual growth rate of 50.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 15.48B | -40.34% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hikal | 22.58B |
| Morepen Laboratories | 21.98B |
| Kwality Pharmaceuticals | 15.55B |
| Amrutanjan Health Care | 15.18B |
| Venus Remedies | 13.90B |
| TTK Healthcare | 12.35B |
| Lincoln Pharmaceuticals | 11.54B |
| Fermenta Biotech | 9.59B |